TNFSF11 and Insulin resistance: The authors were able to ameliorate glucose intolerance by suppressing sRANKL in two independent mouse models hypothesizing that RANKL is a potent activator of NF- κB on hepatocytes promoting cytokine expression and hepatic insulin resistance [13].